The Firm recently advised Novo Holdings for leading the series d investment round of USD 50 Million in MedGenome, a global leader in genetic testing services, genomics research and drug discovery solutions.
Novo Holdings is among the world’s leading life science investors and invests in companies at all stages of development. Along with Novo Holdings as the lead investor, Leapfrog Investments and Sofina also participated in the USD 50 million funding round.
As per the rules of the Bar Council of India, law firms are not permitted to solicit work or
advertise. The information provided on this website is made available solely at your request
for informational purposes only, and should not be construed as soliciting or advertisement.
By clicking "Accept", you acknowledge that there has been no advertisement, solicitation,
invitation, or inducement of any sort whatsoever from Luthra and Luthra Law Offices
India or any of its members to solicit any work through this website.